» Articles » PMID: 25689681

Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPARα) in a Mouse Liver Gene Expression Compendium

Overview
Journal PLoS One
Date 2015 Feb 18
PMID 25689681
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The nuclear receptor family member peroxisome proliferator-activated receptor α (PPARα) is activated by therapeutic hypolipidemic drugs and environmentally-relevant chemicals to regulate genes involved in lipid transport and catabolism. Chronic activation of PPARα in rodents increases liver cancer incidence, whereas suppression of PPARα activity leads to hepatocellular steatosis. Analytical approaches were developed to identify biosets (i.e., gene expression differences between two conditions) in a genomic database in which PPARα activity was altered. A gene expression signature of 131 PPARα-dependent genes was built using microarray profiles from the livers of wild-type and PPARα-null mice after exposure to three structurally diverse PPARα activators (WY-14,643, fenofibrate and perfluorohexane sulfonate). A fold-change rank-based test (Running Fisher's test (p-value ≤ 10(-4))) was used to evaluate the similarity between the PPARα signature and a test set of 48 and 31 biosets positive or negative, respectively for PPARα activation; the test resulted in a balanced accuracy of 98%. The signature was then used to identify factors that activate or suppress PPARα in an annotated mouse liver/primary hepatocyte gene expression compendium of ~1850 biosets. In addition to the expected activation of PPARα by fibrate drugs, di(2-ethylhexyl) phthalate, and perfluorinated compounds, PPARα was activated by benzofuran, galactosamine, and TCDD and suppressed by hepatotoxins acetaminophen, lipopolysaccharide, silicon dioxide nanoparticles, and trovafloxacin. Additional factors that activate (fasting, caloric restriction) or suppress (infections) PPARα were also identified. This study 1) developed methods useful for future screening of environmental chemicals, 2) identified chemicals that activate or suppress PPARα, and 3) identified factors including diets and infections that modulate PPARα activity and would be hypothesized to affect chemical-induced PPARα activity.

Citing Articles

A new approach methodology to identify tumorigenic chemicals using short-term exposures and transcript profiling.

Ledbetter V, Auerbach S, Everett L, Vallanat B, Lowit A, Akerman G Front Toxicol. 2024; 6:1422325.

PMID: 39483698 PMC: 11526388. DOI: 10.3389/ftox.2024.1422325.


Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver.

Pandiri A, Auerbach S, Stevens J, Blomme E Toxicol Pathol. 2024; 51(7-8):470-481.

PMID: 38288963 PMC: 11014763. DOI: 10.1177/01926233241227942.


Hepatic Transcriptome Comparative In Silico Analysis Reveals Similar Pathways and Targets Altered by Legacy and Alternative Per- and Polyfluoroalkyl Substances in Mice.

Robarts D, Dai J, Lau C, Apte U, Corton J Toxics. 2023; 11(12).

PMID: 38133364 PMC: 10748317. DOI: 10.3390/toxics11120963.


Vitamin B2 enables regulation of fasting glucose availability.

Masschelin P, Saha P, Ochsner S, Cox A, Kim K, Felix J Elife. 2023; 12.

PMID: 37417957 PMC: 10328530. DOI: 10.7554/eLife.84077.


Determinants of gene expression in the human liver: Impact of aging and sex on xenobiotic metabolism.

Corton J, Lee J, Liu J, Ren H, Vallanat B, Devito M Exp Gerontol. 2022; 169:111976.

PMID: 36244585 PMC: 10586520. DOI: 10.1016/j.exger.2022.111976.


References
1.
Kersten S, Seydoux J, Peters J, Gonzalez F, Desvergne B, Wahli W . Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999; 103(11):1489-98. PMC: 408372. DOI: 10.1172/JCI6223. View

2.
Leone T, Weinheimer C, Kelly D . A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A. 1999; 96(13):7473-8. PMC: 22110. DOI: 10.1073/pnas.96.13.7473. View

3.
Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters J, Gonzalez F . Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999; 274(45):32048-54. DOI: 10.1074/jbc.274.45.32048. View

4.
Corton J, Anderson S, Stauber A . Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol. 2000; 40:491-518. DOI: 10.1146/annurev.pharmtox.40.1.491. View

5.
Hashimoto T, Cook W, Qi C, Yeldandi A, Reddy J, Rao M . Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem. 2000; 275(37):28918-28. DOI: 10.1074/jbc.M910350199. View